Twitter has rolled back its COVID-19 misinformation policy, as public health experts and researchers have expressed concern that the change would have major repercussions as the virus continues to spread and vaccination numbers remain low. The company’s new CEO, Elon Musk, has signalled an interest in rolling back many of Twitter’s previous rules meant to combat misinformation.
Twitter will no longer enforce its policy against COVID-19 misinformation, raising concerns among public health experts and social media researchers that the change could have serious consequences if it discourages vaccination and other efforts to combat the still-spreading virus.
Eagle-eyed users spotted the change Monday night, noting that a one-sentence update had been made to Twitter’s online rules: „Effective November 23, 2022, Twitter is no longer enforcing the COVID-19 misleading information policy.”
By Tuesday, some Twitter accounts were testing the new boundaries and celebrating the platform’s hands-off approach, which comes after Twitter was purchased by Elon Musk.
“This policy was used to silence people across the world who questioned the media narrative surrounding the virus and treatment options,” tweeted Dr. Simone Gold, a physician and leading purveyor of COVID-19 misinformation. “A win for free speech and medical freedom!”
Twitter’s decision to no longer remove false claims about the safety of COVID-19 vaccines disappointed public health officials, however, who said it could lead to more false claims about the virus, or the safety and effectiveness of vaccines.
“Bad news,” tweeted epidemiologist Eric Feigl-Ding, who urged people not to flee Twitter but to keep up the fight against bad information about the virus. “Stay folks — do NOT cede the town square to them!”
While Twitter’s efforts to stop false claims about COVID weren’t perfect, the company’s decision to reverse course is an abdication of its duty to its users, said Paul Russo, a social media researcher and dean of the Katz School of Science and Health at Yeshiva University in New York.
